Protagonist Therapeutics Inc (PTGX)
46.46
+4.81
(+11.55%)
USD |
NASDAQ |
Nov 22, 16:00
46.45
-0.01
(-0.02%)
After-Hours: 20:00
Protagonist Therapeutics Revenue (TTM): 323.80M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 323.80M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 45.48M |
| March 31, 2022 | 46.89M |
| December 31, 2021 | 27.36M |
| September 30, 2021 | 24.39M |
| Date | Value |
|---|---|
| June 30, 2021 | 27.22M |
| March 31, 2021 | 31.17M |
| December 31, 2020 | 28.63M |
| September 30, 2020 | 25.70M |
| June 30, 2020 | 16.72M |
| March 31, 2020 | 2.318M |
| December 31, 2019 | 0.231M |
| September 30, 2019 | -0.135M |
| June 30, 2019 | 1.841M |
| March 31, 2019 | 21.70M |
| December 31, 2018 | 30.92M |
| September 30, 2018 | 39.85M |
| June 30, 2018 | 42.52M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.231M
Minimum
Dec 2019
323.80M
Maximum
Sep 2024
49.99M
Average
27.29M
Median
Revenue (TTM) Benchmarks
| Johnson & Johnson | 87.70B |
| Assembly Biosciences Inc | 28.33M |
| Precision BioSciences Inc | 75.10M |
| Entrada Therapeutics Inc | 215.23M |
| NovaBay Pharmaceuticals Inc | 13.84M |